EUR 3.14
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 37.2 Million EUR | 109.1% |
2022 | 35.72 Million EUR | 29.65% |
2021 | 27.55 Million EUR | 23.36% |
2020 | 22.33 Million EUR | 22.91% |
2019 | 18.17 Million EUR | -65.51% |
2018 | 52.68 Million EUR | 5.04% |
2017 | 50.16 Million EUR | 15.28% |
2016 | 43.51 Million EUR | 14.8% |
2015 | 37.9 Million EUR | 16.58% |
2014 | 32.51 Million EUR | 21.13% |
2013 | 26.83 Million EUR | -27.55% |
2012 | 37.04 Million EUR | 10.95% |
2011 | 33.38 Million EUR | 0.0% |
2010 | - EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q4 | 20.3 Million EUR | 0.0% |
2023 Q2 | 25.71 Million EUR | 0.0% |
2022 Q2 | 24 Million EUR | 0.0% |
2022 FY | 35.72 Million EUR | 29.65% |
2022 Q4 | 26.96 Million EUR | 0.0% |
2021 Q2 | 15.49 Million EUR | 0.0% |
2021 FY | 27.55 Million EUR | 23.36% |
2021 Q4 | 12.06 Million EUR | 0.0% |
2020 Q2 | 14.31 Million EUR | 0.0% |
2020 Q4 | 12.21 Million EUR | 0.0% |
2020 FY | 22.33 Million EUR | 22.91% |
2019 FY | 18.17 Million EUR | -65.51% |
2019 Q2 | 14.37 Million EUR | 0.0% |
2019 Q4 | 3.79 Million EUR | 0.0% |
2018 Q4 | 18.42 Million EUR | 0.0% |
2018 FY | 52.68 Million EUR | 5.04% |
2018 Q2 | 23.4 Million EUR | 0.0% |
2017 Q4 | 30.43 Million EUR | 0.0% |
2017 Q2 | 19.72 Million EUR | 0.0% |
2017 FY | 50.16 Million EUR | 15.28% |
2016 Q2 | 18.28 Million EUR | 0.0% |
2016 FY | 43.51 Million EUR | 14.8% |
2016 Q4 | 25.22 Million EUR | 0.0% |
2015 Q4 | 20.54 Million EUR | 0.0% |
2015 FY | 37.9 Million EUR | 16.58% |
2015 Q2 | 17.35 Million EUR | 0.0% |
2014 FY | 32.51 Million EUR | 21.13% |
2014 Q4 | 18.5 Million EUR | 0.0% |
2014 Q2 | 14 Million EUR | 0.0% |
2013 Q4 | 15.89 Million EUR | 0.0% |
2013 Q2 | 10.94 Million EUR | 0.0% |
2013 FY | 26.83 Million EUR | -27.55% |
2012 Q1 | 8.34 Million EUR | 0.0% |
2012 Q3 | 9.26 Million EUR | 0.0% |
2012 Q4 | 9.26 Million EUR | 0.0% |
2012 FY | 37.04 Million EUR | 10.95% |
2012 Q2 | 9.26 Million EUR | 10.95% |
2011 Q2 | 8.34 Million EUR | 0.0% |
2011 Q1 | - EUR | 0.0% |
2011 Q4 | 8.34 Million EUR | 0.0% |
2011 FY | 33.38 Million EUR | 0.0% |
2011 Q3 | 8.34 Million EUR | 0.0% |
2010 Q4 | - EUR | 0.0% |
2010 FY | - EUR | 0.0% |
2010 Q2 | - EUR | 0.0% |
2010 Q3 | - EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Crossject Société Anonyme | -6.13 Million EUR | 706.422% |
Safe Orthopaedics SA | 4.1 Million EUR | -806.089% |
Spineway SA | 1.55 Million EUR | -2298.711% |
Sartorius Stedim Biotech S.A. | 1.23 Billion EUR | 96.984% |
EssilorLuxottica Société anonyme | 16.07 Billion EUR | 99.768% |
bonyf N.V. | 26.41 Thousand EUR | -140749.549% |